Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: Impact of epitope orientation

Vaccine

Volumn 16, Issue 1, 1998, Pages 38-44

  Ahlborg, Niklas ^a   Nardin, Elizabeth H ^b   Perlmann, Peter ^a   Berzins, Klavs ^a   Andersson, Roland ^c  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Multiple antigen peptide; Plasmodium falciparum; T cell B cell collaboration

Indexed keywords

ANTIBODY; ANTIGEN; EPITOPE; HUMAN MONOCLONAL ANTIBODY; MALARIA VACCINE; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, PROTOZOAN; B-LYMPHOCYTES; EPITOPES; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMODIUM FALCIPARUM; T-LYMPHOCYTES;

EID: 0031986436     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00155-2     Document Type: Article

References (33)

1. Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigen system. Proc. Natl. Acad. Sci. USA. 85:1988;5409-5413.
2. Herzenberg L.A., Tokuhisa T., Herzenberg L.A. Carrier-priming leads to hapten-specific suppression. Nature. 285:1980;664-667.
3. Herrington D.A., Clyde D.F., Losonsky G.et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature. 328:1987;257-259.
4. Munesinghe D.Y., Clavijo P., Calle M.C., Nussenzweig R.S., Nardin E. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein. Eur. J. Immunol. 21:1991;3015-3020.
5. Pessi A., Valmori D., Migliorini P., Tougne C.et al. Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide. Eur. J. Immunol. 21:1991;2273-2276.
6. Tam J.P., Clavijo P., Lu Y., Nussenzweig V., Nussenzweig R., Zavala F. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171:1990;299-306.
7. Chai S.K., Clavijo P., Tam J.P., Zavala F. Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes. J. Immunol. 149:1992;2385-2390.
8. Francis M.J., Hastings G.Z., Syred A.D., McGinn B., Brown F., Rowlands D.J. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature. 300:1987;168-170.
9. Tam J.P., Lu Y.-A. Vaccine engineering: Enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. Proc. Natl. Acad. Sci. USA. 86:1989;9084-9088.
10. Wang R., Charoenvit Y., Corradin G.et al. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J. Immunol. 154:1995;2784-2793.
11. Calvo-Calle J.M., de Oliveira G.A., Clavijo P.et al. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum. J. Immunol. 150:1993;1403-1412.
12. Nussenzweig V., Nussenzweig R.S. Rationale for development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:1989;283-334.
13. Mattei D., Berzins K., Wahlgren M.et al. Cross-reactive antigenic determinants present on different Plasmodium falciparum blood-stage antigens. Parasite Immunol. 11:1989;15-30.
14. Mattei D., Scherf A. The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes. Gene. 110:1992;71-79.
15. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T., Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172:1990;1633-1641.
16. Zavala F. The multifactorial character of the protective immunity induced by immunization with sporozoites. Res. Immunol. 142:1991;654-658.
17. Burkot T.R., Wen Da Z., Geysen H.M., Wirtz R.A., Saul A. Fine specificities of monoclonal antibodies against the Plasmodium falciparum circumsporozoite protein: recognition of both repetitive and non-repetitive regions. Parasite Immunol. 13:1991;161-170.
18. Hollingdale M.R., Nardin E.H., Tharavanij S., Schwartz A.L., Nussenzweig R.S. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells: an in vitro assay of protective antibodies. J. Immunol. 132:1984;909-913.
19. Nardin E.H., Nussenzweig V., Nussenzweig R.S.et al. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J. Exp. Med. 156:1982;20-30.
20. Kun J., Hesselbach J., Schreiber M.et al. Cloning and expression of genomic DNA sequences coding for putative erythrocyte membrane-associated antigens of Plasmodium falciparum. Res. Immunol. 142:1991;199-210.
21. Ahlborg N., Berzins K., Perlmann P. Definition of the epitope recognized by the Plasmodium falciparum-reactive human monoclonal antibody 33G2. Mol. Biochem. Parasitol. 46:1991;89-96.
22. Udomsangpetch R., Carlsson J., Wåhlin B.et al. Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens. J. Immunol. 142:1989;3620-3626.
23. Ahlborg N., Andersson R., Perlmann P., Berzins K. Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332. Immunology. 88:1996;630-675.
24. Ahlborg N., Iqbal J., Hansson M.et al. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence. Parasite Immunol. 17:1995;341-352.
25. Ahlborg N. Synthesis of a diepitope MAP containing two malaria antigen sequences using Fmoc chemistry. J. Immunol. Methods. 179:1995;269-275.
26. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
27. Perlmann H., Berzins K., Wahlgren M.et al. Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early stages of Plasmodium falciparum. J. Exp. Med. 159:1984;1686-1704.
28. Nardin E., Gwadz R.W., Nussenzweig R.S. Characterization of sporozoite surface antigens by indirect immunofluorescence: detection of stage- and species-specific antimalarial antibodies. Bull. WHO. 57 (Suppl. 1):1979;211-217.
29. Bellone M., Karachunski P.I., Ostlie N., Lei S., Conti-Tronconi B.M. Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes. Eur. J. Immunol. 24:1994;799-804.
30. Prieto I., Hervás-Stubbs S., García-Granero M.et al. Simple strategy to induce antibodies of distinct specificity: application to the mapping of gp120 and inhibition of HIV-1 infectivity. Eur. J. Immunol. 25:1995;877-883.
31. Zegers N.D., van Holten C., Claassen E., Boersma W.J.A. Peptide-induced memory (IgG) response, cross-reactive with native proteins, requires covalent linkage of a specific B cell epitope with a T cell epitope. Eur. J. Immunol. 23:1993;630-634.
32. Grillot D., Valmori D., Lambert P.-H., Corradin G., Del Guidice G. Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes. Infect. Immun. 61:1993;3064-3067.
33. Glass E.J., Miller P. Bovine T cells preferentially recognize non-viral spacer epitopes in a putative FMDV vaccinal peptide. Vaccine. 13:1995;225-229.